{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:08Z","timestamp":1789632188344,"version":"build-2803163510"},"reference-count":245,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15800","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:58:32Z","timestamp":1785844712000},"page":"1-18","source":"Crossref","is-referenced-by-count":0,"title":["Subtype\u2011specific mechanisms of lipid metabolism in gynecological malignancies and novel targeted intervention strategies (Review)"],"prefix":"10.3892","volume":"32","author":[{"given":"Yidan","family":"Ran","sequence":"first","affiliation":[{"name":"Medical College, Henan Polytechnic University, Jiaozuo, Henan 454150, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"key20260917101219_b1-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-025-02411-w","article-title":"Advances and obstacles of T cell-based immunotherapy in gynecological malignancies","volume":"24","author":"Zhao","year":"2025","journal-title":"Mol Cancer"},{"key":"key20260917101219_b2-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ijgc-2024-005299","article-title":"Surgery for gynecological cancers in the era of personalized medicine: A novel paradigm","volume":"34","author":"Fotopoulou","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"key20260917101219_b3-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"155611","DOI":"10.1016\/j.prp.2024.155611","article-title":"PROTACs in gynecological cancers: Current knowledge and future potential as a treatment strategy","volume":"263","author":"Movahed","year":"2024","journal-title":"Pathol Res Pract"},{"key":"key20260917101219_b4-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1016\/S1470-2045(24)00262-6","article-title":"Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: Guidelines from ESGO, ESHRE, and ESGE","volume":"25","author":"Morice","year":"2024","journal-title":"Lancet Oncol"},{"key":"key20260917101219_b5-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.it.2024.12.006","article-title":"Immune evasion in ovarian cancer: Implications for immunotherapy and emerging treatments","volume":"46","author":"Gupta","year":"2025","journal-title":"Trends Immunol"},{"key":"key20260917101219_b6-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/JS9.0000000000003398","article-title":"Global, regional, and national burden of ovarian cancer, 1990\u20132021, and projections to 2050: A cross-sectional analysis of the Global Burden of Disease Study 2021","volume":"112","author":"Xie","year":"2026","journal-title":"Int J Surg"},{"key":"key20260917101219_b7-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"04155","DOI":"10.7189\/jogh.14.04155","article-title":"Global burden of gynaecological cancers in 2022 and projections to 2050","volume":"14","author":"Zhu","year":"2024","journal-title":"J Glob Health"},{"key":"key20260917101219_b8-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12967-022-03851-4","article-title":"Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer","volume":"21","author":"Huang","year":"2023","journal-title":"J Transl Med"},{"key":"key20260917101219_b9-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"key20260917101219_b10-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"127857","DOI":"10.1016\/j.micres.2024.127857","article-title":"Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential","volume":"287","author":"Huang","year":"2024","journal-title":"Microbiol Res"},{"key":"key20260917101219_b11-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/vaccines12111293","article-title":"Human papillomavirus (HPV) vaccination: Progress, challenges, and future directions in global immunization strategies","volume":"12","author":"Branda","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"key20260917101219_b12-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/cac2.12629","article-title":"Advances in cervical cancer: Current insights and future directions","volume":"45","author":"Xu","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"key20260917101219_b13-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/ijgc-2021-003001","article-title":"Global challenges of radiotherapy for the treatment of locally advanced cervical cancer","volume":"32","author":"Mayadev","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"key20260917101219_b14-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/cncr.30667","article-title":"Cervical cancer: A global health crisis","volume":"123","author":"Small","year":"2017","journal-title":"Cancer"},{"key":"key20260917101219_b15-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: An emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett"},{"key":"key20260917101219_b16-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"114526","DOI":"10.1016\/j.biopha.2023.114526","article-title":"Metabolic reprogramming and interventions in endometrial carcinoma","volume":"161","author":"Li","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"key20260917101219_b17-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12986-021-00615-7","article-title":"Metabolic reprogramming in cervical cancer and metabolomics perspectives","volume":"18","author":"Li","year":"2021","journal-title":"Nutr Metab (Lond)"},{"key":"key20260917101219_b18-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/ijms25010075","article-title":"Ferroptosis, metabolic rewiring, and endometrial cancer","volume":"25","author":"\u017dalyt\u0117","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b19-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"key20260917101219_b20-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41586-024-08071-y","article-title":"Transgelin 2 guards T cell lipid metabolism and antitumour function","volume":"635","author":"Hwang","year":"2024","journal-title":"Nature"},{"key":"key20260917101219_b21-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-24-3209","article-title":"Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res"},{"key":"key20260917101219_b22-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e20210042","DOI":"10.1084\/jem.20210042","article-title":"Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function","volume":"219","author":"Dyck","year":"2022","journal-title":"J Exp Med"},{"key":"key20260917101219_b23-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e1219","DOI":"10.1002\/ctm2.1219","article-title":"Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome","volume":"13","author":"Guo","year":"2023","journal-title":"Clin Transl Med"},{"key":"key20260917101219_b24-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/aogs.13106","article-title":"Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer","volume":"96","author":"Shafiee","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key20260917101219_b25-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3960\/jslrt.22023","article-title":"Cholesterol metabolism and lipid droplet vacuoles; a potential target for the therapy of aggressive lymphoma","volume":"62","author":"Yano","year":"2022","journal-title":"J Clin Exp Hematop"},{"key":"key20260917101219_b26-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"8081","DOI":"10.2147\/CMAR.S211912","article-title":"The role of low density lipoprotein receptor-related protein 11 as a tumor promoter in cervical cancer","volume":"11","author":"Wang","year":"2019","journal-title":"Cancer Manag Res"},{"key":"key20260917101219_b27-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"key20260917101219_b28-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"746151","DOI":"10.3389\/fimmu.2021.746151","article-title":"Meta-Inflammation and metabolic reprogramming of macrophages in diabetes and obesity: The importance of metabolites","volume":"12","author":"Russo","year":"2021","journal-title":"Front Immunol"},{"key":"key20260917101219_b29-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"75","DOI":"10.7150\/thno.83051","article-title":"MK8722 initiates early-stage autophagy while inhibiting late-stage autophagy via FASN-dependent reprogramming of lipid metabolism","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"key":"key20260917101219_b30-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/genes15111358","article-title":"Metabolic and epigenetic mechanisms in hepatoblastoma: Insights into tumor biology and therapeutic targets","volume":"15","author":"Fu","year":"2024","journal-title":"Genes (Basel)"},{"key":"key20260917101219_b31-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: Insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol Cancer"},{"key":"key20260917101219_b32-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20260917101219_b33-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10495-022-01795-0","article-title":"Targeting lipid metabolism for ferroptotic cancer therapy","volume":"28","author":"Luo","year":"2023","journal-title":"Apoptosis"},{"key":"key20260917101219_b34-ol-32-4-15800","first-page":"743","article-title":"Vaginal microbiomes and ovarian cancer: A review","volume":"10","author":"Xu","year":"2020","journal-title":"Am J Cancer Res"},{"key":"key20260917101219_b35-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: A review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"key":"key20260917101219_b36-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41419-022-05014-1","article-title":"Ct-OATP1B3 promotes high-grade serous ovarian cancer metastasis by regulation of fatty acid beta-oxidation and oxidative phosphorylation","volume":"13","author":"Huang","year":"2022","journal-title":"Cell Death Dis"},{"key":"key20260917101219_b37-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"100471","DOI":"10.1016\/j.xcrm.2021.100471","article-title":"Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer","volume":"2","author":"Huang","year":"2021","journal-title":"Cell Rep Med"},{"key":"key20260917101219_b38-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/1541-7786.MCR-19-1057","article-title":"Targeting fatty acid oxidation to promote anoikis and inhibit ovarian cancer progression","volume":"18","author":"Sawyer","year":"2020","journal-title":"Mol Cancer Res"},{"key":"key20260917101219_b39-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.humpath.2023.09.001","article-title":"LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma","volume":"141","author":"Kolb","year":"2023","journal-title":"Hum Pathol"},{"key":"key20260917101219_b40-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00428-020-02795-8","article-title":"The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy","volume":"477","author":"van Baal","year":"2020","journal-title":"Virchows Arch"},{"key":"key20260917101219_b41-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1437161","DOI":"10.3389\/fphar.2024.1437161","article-title":"Lipid droplets: A candidate new research field for epithelial ovarian cancer","volume":"15","author":"Koizume","year":"2024","journal-title":"Front Pharmacol"},{"key":"key20260917101219_b42-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e2411314","DOI":"10.1002\/advs.202411314","article-title":"PLIN2 promotes lipid accumulation in ascites-associated macrophages and ovarian cancer progression by HIF1\u03b1\/SPP1 signaling","volume":"12","author":"Luo","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"key20260917101219_b43-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e2416467","DOI":"10.1002\/advs.202416467","article-title":"ACAT1-Mediated ME2 acetylation drives chemoresistance in ovarian cancer by linking glutaminolysis to lactate production","volume":"12","author":"Zheng","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"key20260917101219_b44-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"155465","DOI":"10.1016\/j.prp.2024.155465","article-title":"Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target","volume":"260","author":"Ahmad","year":"2024","journal-title":"Pathol Res Pract"},{"key":"key20260917101219_b45-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/2767-9764.CRC-23-0030","article-title":"Targeting fatty acid reprogramming suppresses CARM1-expressing ovarian cancer","volume":"3","author":"Lombardi","year":"2023","journal-title":"Cancer Res Commun"},{"key":"key20260917101219_b46-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3389\/fimmu.2018.02927","article-title":"Ovarian cancer-intrinsic fatty acid synthase prevents anti-tumor immunity by disrupting tumor-infiltrating dendritic cells","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Immunol"},{"key":"key20260917101219_b47-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1002\/cam4.5612","article-title":"Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean epithelial ovarian cancer study (Ko-EVE)","volume":"12","author":"Sung","year":"2023","journal-title":"Cancer Med"},{"key":"key20260917101219_b48-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"156367","DOI":"10.1016\/j.phymed.2025.156367","article-title":"Melittin suppresses ovarian cancer growth by regulating SREBP1-mediated lipid metabolism","volume":"137","author":"Wu","year":"2025","journal-title":"Phytomedicine"},{"key":"key20260917101219_b49-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"593017","DOI":"10.3389\/fonc.2020.593017","article-title":"Deregulation of lipid metabolism: The critical factors in ovarian cancer","volume":"10","author":"Ji","year":"2020","journal-title":"Front Oncol"},{"key":"key20260917101219_b50-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"24990","DOI":"10.1074\/jbc.M112.340083","article-title":"Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells","volume":"287","author":"Mukherjee","year":"2012","journal-title":"J Biol Chem"},{"key":"key20260917101219_b51-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1080\/15384047.2017.1394547","article-title":"Estrogen and insulin synergistically promote type 1 endometrial cancer progression","volume":"18","author":"Tian","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"key20260917101219_b52-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, diabetes, and increased cancer progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab J"},{"key":"key20260917101219_b53-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/IGC.0000000000000004","article-title":"Sterol regulatory element-binding protein-1\/fatty acid synthase involvement in proliferation inhibition and apoptosis promotion induced by progesterone in endometrial cancer","volume":"23","author":"Qiu","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"key20260917101219_b54-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.2147\/IJWH.S468733","article-title":"Genetically proxied therapeutic effect of lipid-lowering drugs use, breast cancer, and endometrial cancer's risk: A drug target-based mendelian Randomization study","volume":"16","author":"Dang","year":"2024","journal-title":"Int J Womens Health"},{"key":"key20260917101219_b55-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.3390\/ijms25115893","article-title":"Molecular classification of endometrial cancer and its impact on therapy selection","volume":"25","author":"Galant","year":"2024","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b56-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00404-019-05181-1","article-title":"Type-II endometrial cancer: Role of adipokines","volume":"300","author":"Garikapati","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"key20260917101219_b57-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s11523-016-0442-9","article-title":"Effects of Fatty acid synthase inhibition by orlistat on proliferation of endometrial cancer cell lines","volume":"11","author":"Wysham","year":"2016","journal-title":"Target Oncol"},{"key":"key20260917101219_b58-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"116850","DOI":"10.1016\/j.bcp.2025.116850","article-title":"Strategic advancements in targeting the PI3K\/AKT\/mTOR pathway for Breast cancer therapy","volume":"236","author":"Garg","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"key20260917101219_b59-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"102861","DOI":"10.1016\/j.ctrv.2024.102861","article-title":"PI3K\/AKT\/mTOR inhibitors for hormone receptor-positive advanced breast cancer","volume":"132","author":"Hao","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"key20260917101219_b60-ol-32-4-15800","first-page":"CD012160","article-title":"PI3K\/AKT\/mTOR inhibitors for advanced or recurrent endometrial cancer","volume":"10","author":"Roncolato","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"(Pt 3)","key":"key20260917101219_b61-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semcancer.2022.03.005","article-title":"Vaginal microbiome and cervical cancer","volume":"86","author":"Kyrgiou","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"key20260917101219_b62-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bpobgyn.2020.02.008","article-title":"Primary HPV screening for cervical cancer","volume":"65","author":"Bhatla","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key20260917101219_b63-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fmicb.2019.03116","article-title":"Human Papillomavirus E6 and E7: The cervical cancer hallmarks and targets for therapy","volume":"10","author":"Pal","year":"2020","journal-title":"Front Microbiol"},{"key":"key20260917101219_b64-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7150\/ijbs.67770","article-title":"HPV E6\/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m(6)A-MYC expression","volume":"18","author":"Hu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"key20260917101219_b65-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e244090","DOI":"10.1001\/jamanetworkopen.2024.4090","article-title":"Cervical cancer screening via visual inspection with acetic acid and lugol iodine for triage of HPV-Positive women","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"key20260917101219_b66-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/hed.26159","article-title":"Thyroid cancer histological subtypes based on tumor size: National perspective","volume":"42","author":"Al-Qurayshi","year":"2020","journal-title":"Head Neck"},{"key":"key20260917101219_b67-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s44197-023-00172-7","article-title":"Global cervical cancer incidence by histological subtype and implications for screening methods","volume":"14","author":"Wang","year":"2024","journal-title":"J Epidemiol Glob Health"},{"key":"key20260917101219_b68-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"eadd8977","DOI":"10.1126\/sciadv.add8977","article-title":"Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression","volume":"9","author":"Liu","year":"2023","journal-title":"Sci Adv"},{"key":"key20260917101219_b69-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ygyno.2021.12.018","article-title":"Post-recurrence survival in patients with cervical cancer","volume":"164","author":"Cibula","year":"2022","journal-title":"Gynecol Oncol"},{"key":"key20260917101219_b70-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ebiom.2019.04.028","article-title":"Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling","volume":"44","author":"Ilhan","year":"2019","journal-title":"EBioMedicine"},{"key":"key20260917101219_b71-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/v15071440","article-title":"Recent developments in human papillomavirus (HPV) vaccinology","volume":"15","author":"Williamson","year":"2023","journal-title":"Viruses"},{"key":"key20260917101219_b72-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12967-025-06470-x","article-title":"Human papilloma virus (HPV) mediated cancers: An insightful update","volume":"23","author":"Baba","year":"2025","journal-title":"J Transl Med"},{"key":"key20260917101219_b73-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","article-title":"Mitochondrial metabolism and cancer therapeutic innovation","volume":"10","author":"Du","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"key20260917101219_b74-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"146137","DOI":"10.1016\/j.gene.2021.146137","article-title":"The multifaceted role of Matricellular Proteins in health and cancer, as biomarkers and therapeutic targets","volume":"815","author":"Gopinath","year":"2022","journal-title":"Gene"},{"key":"key20260917101219_b75-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/cells8070662","article-title":"The impact of the adipose organ plasticity on inflammation and cancer progression","volume":"8","author":"Corr\u00eaa","year":"2019","journal-title":"Cells"},{"key":"key20260917101219_b76-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"eadr4795","DOI":"10.1126\/sciimmunol.adr4795","article-title":"Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer","volume":"10","author":"Slattery","year":"2025","journal-title":"Sci Immunol"},{"key":"key20260917101219_b77-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ceca.2019.06.002","article-title":"Lipid metabolism and Calcium signaling in epithelial ovarian cancer","volume":"81","author":"Kouba","year":"2019","journal-title":"Cell Calcium"},{"key":"key20260917101219_b78-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"103528","DOI":"10.1016\/j.redox.2025.103528","article-title":"Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis","volume":"80","author":"Jin","year":"2025","journal-title":"Redox Biol"},{"key":"key20260917101219_b79-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","article-title":"Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis","volume":"37","author":"Ladanyi","year":"2018","journal-title":"Oncogene"},{"key":"key20260917101219_b80-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s42003-025-09346-4","article-title":"Elevated CD36 drives lymph node metastasis of breast cancer by activating Hippo-YAP signaling-mediated anoikis resistance","volume":"9","author":"Huang","year":"2025","journal-title":"Commun Biol"},{"key":"key20260917101219_b81-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1038\/s41388-025-03609-4","article-title":"High serum LDL promotes EMT and stemness through LDLR\/FOXQ1\/NF-\u03baB1 pathway in epithelial ovarian cancer","volume":"44","author":"Tang","year":"2025","journal-title":"Oncogene"},{"key":"key20260917101219_b82-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.metabol.2019.02.002","article-title":"Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome","volume":"94","author":"Wang","year":"2019","journal-title":"Metabolism"},{"key":"key20260917101219_b83-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3390\/cells9040828","article-title":"Cholesterol homeostasis modulates platinum sensitivity in human ovarian cancer","volume":"9","author":"Criscuolo","year":"2020","journal-title":"Cells"},{"key":"key20260917101219_b84-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.prostaglandins.2016.02.002","article-title":"Expression of the energy substrate transporters in uterine fibroids","volume":"123","author":"Knapp","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"key20260917101219_b85-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"610885","DOI":"10.3389\/fonc.2021.610885","article-title":"The pharmacological or genetic blockade of endogenous de novo fatty acid synthesis does not increase the uptake of exogenous lipids in ovarian cancer cells","volume":"11","author":"Grunt","year":"2021","journal-title":"Front Oncol"},{"key":"key20260917101219_b86-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.3390\/cancers14236004","article-title":"Pharmacological inhibition of lipid import and transport proteins in ovarian cancer","volume":"14","author":"Lemberger","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20260917101219_b87-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"111135","DOI":"10.1016\/j.mce.2020.111135","article-title":"BF175 inhibits endometrial carcinoma through SREBP-regulated metabolic pathways in vitro","volume":"523","author":"Wang","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"key20260917101219_b88-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1089\/gtmb.2019.0192","article-title":"Visfatin and SREBP-1c mRNA expressions and serum levels among egyptian women with polycystic ovary syndrome","volume":"24","author":"Abdul-Maksoud","year":"2020","journal-title":"Genet Test Mol Biomarkers"},{"key":"key20260917101219_b89-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41419-022-04926-2","article-title":"FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis","volume":"13","author":"Du","year":"2022","journal-title":"Cell Death Dis"},{"key":"key20260917101219_b90-ol-32-4-15800","first-page":"1919","article-title":"Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma","volume":"39","author":"Gao","year":"2018","journal-title":"Oncol Rep"},{"key":"key20260917101219_b91-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"102396","DOI":"10.1016\/j.tranon.2025.102396","article-title":"Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer","volume":"56","author":"Wang","year":"2025","journal-title":"Transl Oncol"},{"key":"key20260917101219_b92-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"154102","DOI":"10.1016\/j.phymed.2022.154102","article-title":"Agrimonolide inhibits cancer progression and induces ferroptosis and apoptosis by targeting SCD1 in ovarian cancer cells","volume":"101","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"key20260917101219_b93-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e004616","DOI":"10.1136\/jitc-2022-004616","article-title":"Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating \u03b2-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody","volume":"10","author":"Katoh","year":"2022","journal-title":"J Immunother Cancer"},{"key":"key20260917101219_b94-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"13116","DOI":"10.1038\/s41598-024-64043-2","article-title":"FADS2 confers SCD1 inhibition resistance to cancer cells by modulating the ER stress response","volume":"14","author":"Ikeda","year":"2024","journal-title":"Sci Rep"},{"key":"key20260917101219_b95-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e21525","DOI":"10.1002\/advs.202521525","article-title":"PROTAC?Mediated HMGCR depletion reprograms lipid metabolism in breast cancer to potentiate photoimmunotherapy via ferroptosis","volume":"13","author":"Su","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"key20260917101219_b96-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"216609","DOI":"10.1016\/j.canlet.2024.216609","article-title":"DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4\/PI3K\/AKT axis and VEGF-C secretion","volume":"584","author":"Mei","year":"2024","journal-title":"Cancer Lett"},{"key":"key20260917101219_b97-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1573686","DOI":"10.3389\/fimmu.2025.1573686","article-title":"Organoid models of ovarian cancer: Resolving immune mechanisms of metabolic reprogramming and drug resistance","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"key20260917101219_b98-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e184935","DOI":"10.1172\/jci.insight.184935","article-title":"Complement activation at the interface between adipocytes and cancer cells drives tumor progression","volume":"10","author":"Valdivia","year":"2025","journal-title":"JCI Insight"},{"key":"key20260917101219_b99-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1186\/s12885-023-11234-1","article-title":"A nomogram prediction model for the TP53mut subtype in endometrial cancer based on preoperative noninvasive parameters","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"key":"key20260917101219_b100-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s41419-020-03207-0","article-title":"The dynamic behavior of lipid droplets in the pre-metastatic niche","volume":"11","author":"Shang","year":"2020","journal-title":"Cell Death Dis"},{"key":"key20260917101219_b101-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e70051","DOI":"10.1111\/cpr.70051","article-title":"GANT61 modulates autophagy and lipid metabolism in ovarian cancer","volume":"58","author":"Pan","year":"2025","journal-title":"Cell Prolif"},{"key":"key20260917101219_b102-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/ijc.32138","article-title":"LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer","volume":"145","author":"Cadenas","year":"2019","journal-title":"Int J Cancer"},{"key":"key20260917101219_b103-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41389-025-00566-1","article-title":"Lipid droplet-associated hydrolase (LDAH) knockdown enhances TAG hydrolysis and promotes ovarian cancer progression and chemoresistance","volume":"14","author":"Deswal","year":"2025","journal-title":"Oncogenesis"},{"key":"key20260917101219_b104-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e0228024","DOI":"10.1371\/journal.pone.0228024","article-title":"Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression-An in vitro study","volume":"15","author":"Ayyagari","year":"2020","journal-title":"PLoS One"},{"key":"key20260917101219_b105-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s12951-025-03667-6","article-title":"A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5-DUSP1 axis for mitochondrial repair","volume":"23","author":"Shi","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"key20260917101219_b106-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","article-title":"Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction","volume":"27","author":"Pang","year":"2024","journal-title":"Angiogenesis"},{"key":"key20260917101219_b107-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13046-020-01794-6","article-title":"Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells","volume":"40","author":"Rizzo","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260917101219_b108-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41419-022-05291-w","article-title":"DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHK\u03b1 to disrupt choline metabolism","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis"},{"key":"key20260917101219_b109-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e2308422","DOI":"10.1002\/advs.202308422","article-title":"Fatty acid oxidation supports lymph node metastasis of cervical cancer via Acetyl-CoA-Mediated stemness","volume":"11","author":"Yuan","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"key20260917101219_b110-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1705354","DOI":"10.3389\/fimmu.2025.1705354","article-title":"CAR-NK cell for gynecological cancers: Immune microenvironment remodeling and immunotherapeutic strategies","volume":"16","author":"Huang","year":"2025","journal-title":"Front Immunol"},{"key":"key20260917101219_b111-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.celrep.2016.02.004","article-title":"Fatty acid oxidation-driven src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast cancer","volume":"14","author":"Park","year":"2016","journal-title":"Cell Rep"},{"key":"key20260917101219_b112-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12951-025-03420-z","article-title":"Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance","volume":"23","author":"Wang","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"key20260917101219_b113-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.7150\/ijbs.95853","article-title":"Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia\/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy","volume":"20","author":"Wang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"key20260917101219_b114-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"16589","DOI":"10.3390\/ijms242316589","article-title":"Adipocyte microenvironment in ovarian cancer: A critical contributor?","volume":"24","author":"Duarte Mendes","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b115-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"10692","DOI":"10.3390\/ijms231810692","article-title":"Immune tumor microenvironment in ovarian cancer ascites","volume":"23","author":"Almeida-Nunes","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b116-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2020.12.079","article-title":"LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway","volume":"537","author":"Takahashi","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"key20260917101219_b117-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.3390\/ijms23126857","article-title":"Orchestrated Action of AMPK activation and combined VEGF\/PD-1 blockade with lipid metabolic tunning as multi-target therapeutics against ovarian cancers","volume":"23","author":"Yung","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b118-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1111\/febs.70193","article-title":"Altered fatty acid oxidation via CPT1A promotes epithelial-to-mesenchymal transition in ovarian cancer","volume":"292","author":"Pakhira","year":"2025","journal-title":"FEBS J"},{"key":"key20260917101219_b119-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1158\/0008-5472.CAN-23-0555","article-title":"Adipose triglyceride lipase is a therapeutic target in advanced prostate cancer that promotes metabolic plasticity","volume":"84","author":"Awad","year":"2024","journal-title":"Cancer Res"},{"key":"key20260917101219_b120-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"189208","DOI":"10.1016\/j.bbcan.2024.189208","article-title":"Mechanisms of cancer cachexia and targeted therapeutic strategies","volume":"1879","author":"Li","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"key20260917101219_b121-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"47","DOI":"10.31083\/j.fbl2803047","article-title":"Potential therapeutic targets in ovarian cancer: Autophagy and metabolism","volume":"28","author":"Park","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key20260917101219_b122-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00018-022-04595-6","article-title":"Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK\/mTOR\/ERK signaling","volume":"79","author":"Ashraf","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"key20260917101219_b123-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"123966","DOI":"10.1016\/j.lfs.2025.123966","article-title":"Autophagy regulation in ovarian cancer chemoresistance: Molecular mechanisms and emerging frontiers","volume":"380","author":"Yang","year":"2025","journal-title":"Life Sci"},{"key":"key20260917101219_b124-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5732\/cjc.014.10289","article-title":"The PI3K\/Akt\/mTOR pathway in ovarian cancer: Therapeutic opportunities and challenges","volume":"34","author":"Cheaib","year":"2015","journal-title":"Chin J Cancer"},{"key":"key20260917101219_b125-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ygyno.2015.02.003","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in ovarian cancer","volume":"137","author":"Mabuchi","year":"2015","journal-title":"Gynecol Oncol"},{"key":"key20260917101219_b126-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.semcancer.2019.05.012","article-title":"Role of the PI3K\/AKT\/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance","volume":"59","author":"Ediriweera","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"key20260917101219_b127-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/cancers11070949","article-title":"PI3K-AKT-mTOR and NFkappaB pathways in ovarian cancer: Implications for targeted therapeutics","volume":"11","author":"Ghoneum","year":"2019","journal-title":"Cancers (Basel)"},{"key":"key20260917101219_b128-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"149352","DOI":"10.1016\/j.gene.2025.149352","article-title":"Overcoming drug resistance in ovarian cancer through PI3K\/AKT signaling inhibitors","volume":"948","author":"Agrawal","year":"2025","journal-title":"Gene"},{"key":"key20260917101219_b129-ol-32-4-15800","first-page":"610","article-title":"The HIPPO pathway in gynecological malignancies","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"key20260917101219_b130-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1273345","DOI":"10.3389\/fonc.2023.1273345","article-title":"The Hippo pathway in endometrial cancer: A potential therapeutic target?","volume":"13","author":"Shen","year":"2023","journal-title":"Front Oncol"},{"key":"key20260917101219_b131-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1038\/s41388-023-02853-w","article-title":"S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1\/2-YAP pathway","volume":"42","author":"Tao","year":"2023","journal-title":"Oncogene"},{"key":"key20260917101219_b132-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41388-022-02550-0","article-title":"Loss-of-function mutations of SOX17 lead to YAP\/TEAD activation-dependent malignant transformation in endometrial cancer","volume":"42","author":"Wang","year":"2023","journal-title":"Oncogene"},{"key":"key20260917101219_b133-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41392-020-0170-6","article-title":"p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer","volume":"5","author":"Wen","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"key20260917101219_b134-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"175503","DOI":"10.1016\/j.ejphar.2023.175503","article-title":"Targeting the NRF2\/KEAP1 pathway in cervical and endometrial cancers","volume":"941","author":"Tossetta","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"key20260917101219_b135-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.freeradbiomed.2024.02.004","article-title":"\u03b2-Sitosterol targets ASS1 for Nrf2 ubiquitin-dependent degradation, inducing ROS-mediated apoptosis via the PTEN\/PI3K\/AKT signaling pathway in ovarian cancer","volume":"214","author":"Wang","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"key20260917101219_b136-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/antiox11040663","article-title":"Role of NRF2 in ovarian cancer","volume":"11","author":"Tossetta","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"key20260917101219_b137-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3892\/ol.2022.13479","article-title":"Norcantharidin induces ferroptosis via the suppression of NRF2\/HO-1 signaling in ovarian cancer cells","volume":"24","author":"Zhu","year":"2022","journal-title":"Oncol Lett"},{"key":"key20260917101219_b138-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/IGC.0000000000000908","article-title":"Expression patterns of Nrf2 and Keap1 in ovarian cancer cells and their prognostic role in disease recurrence and patient survival","volume":"27","author":"Cho","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"key20260917101219_b139-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"15263","DOI":"10.3390\/ijms232315263","article-title":"New insights into ferroptosis initiating therapies (FIT) by targeting the rewired lipid metabolism in ovarian cancer peritoneal metastases","volume":"23","author":"Zhan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b140-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.2147\/CMAR.S538281","article-title":"Metabolic reprogramming shapes the progression and therapeutic landscape of ovarian cancer","volume":"17","author":"Liu","year":"2025","journal-title":"Cancer Manag Res"},{"key":"key20260917101219_b141-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-022-02408-z","article-title":"The pleiotropic roles of adipocyte secretome in remodeling breast cancer","volume":"41","author":"Zhou","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260917101219_b142-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41420-024-01898-4","article-title":"Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K\/AKT\/HIF-1\u03b1 signal pathway in endometrial carcinoma","volume":"10","author":"Wei","year":"2024","journal-title":"Cell Death Discov"},{"key":"key20260917101219_b143-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"876257","DOI":"10.3389\/fonc.2022.876257","article-title":"OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K\/AKT\/mTOR pathway","volume":"12","author":"Xie","year":"2022","journal-title":"Front Oncol"},{"key":"key20260917101219_b144-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"111404","DOI":"10.1016\/j.cellsig.2024.111404","article-title":"ALOX5 induces EMT and promotes cell metastasis via the LTB4\/BLT2\/PI3K\/AKT pathway in ovarian cancer","volume":"124","author":"Ji","year":"2024","journal-title":"Cell Signal"},{"key":"key20260917101219_b145-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"787","DOI":"10.17305\/bb.2024.10508","article-title":"Metabolic dysregulation in obese women and the carcinogenesis of gynecological tumors: A review","volume":"24","author":"Tomi Nagli","year":"2024","journal-title":"Biomol Biomed"},{"key":"key20260917101219_b146-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13046-021-02091-6","article-title":"TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA\/ROCK pathway","volume":"40","author":"Wei","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260917101219_b147-ol-32-4-15800","first-page":"4151","article-title":"miRNA-574-3p inhibits metastasis and chemoresistance of epithelial ovarian cancer (EOC) by negatively regulating epidermal growth factor receptor (EGFR)","volume":"11","author":"Zhang","year":"2019","journal-title":"Am J Transl Res"},{"key":"key20260917101219_b148-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/ph16060849","article-title":"Aptamers versus vascular endothelial growth factor (VEGF): A new battle against ovarian cancer","volume":"16","author":"Mishra","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"key20260917101219_b149-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41388-022-02539-9","article-title":"TARDBP promotes ovarian cancer progression by altering vascular endothelial growth factor splicing","volume":"42","author":"He","year":"2023","journal-title":"Oncogene"},{"key":"key20260917101219_b150-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-024-02216-3","article-title":"Targeting KRAS: From metabolic regulation to cancer treatment","volume":"24","author":"Shi","year":"2025","journal-title":"Mol Cancer"},{"key":"key20260917101219_b151-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1038\/s41388-022-02241-w","article-title":"Targeted siRNA nanocarrier: A platform technology for cancer treatment","volume":"41","author":"B\u00e4umer","year":"2022","journal-title":"Oncogene"},{"key":"key20260917101219_b152-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2174\/0115748928322627241016120142","article-title":"Selinexor as a therapeutic target: Advances in non-small cell and small cell lung cancer treatment strategies","volume":"20","author":"Zheng","year":"2025","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"key20260917101219_b153-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/kjm2.12696","article-title":"LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K\/AKT\/mTOR signaling pathway","volume":"39","author":"Liu","year":"2023","journal-title":"Kaohsiung J Med Sci"},{"key":"key20260917101219_b154-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"16503","DOI":"10.3390\/ijms242216503","article-title":"Resensitizing paclitaxel-resistant ovarian cancer via targeting lipid metabolism key enzymes CPT1A, SCD and FASN","volume":"24","author":"Ma","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b155-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-024-02025-8","article-title":"PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"key20260917101219_b156-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3892\/or.2022.8293","article-title":"Molecular mechanisms of platinum?based chemotherapy resistance in ovarian cancer (Review)","volume":"47","author":"Yang","year":"2022","journal-title":"Oncol Rep"},{"key":"key20260917101219_b157-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"112122","DOI":"10.1016\/j.cellsig.2025.112122","article-title":"Targeting ferroptosis in cervical cancer: Mechanistic insights and therapeutic opportunities","volume":"136","author":"An","year":"2025","journal-title":"Cell Signal"},{"key":"key20260917101219_b158-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1158\/0008-5472.CAN-21-4369","article-title":"Monounsaturated and diunsaturated fatty acids sensitize cervical cancer to radiation therapy","volume":"82","author":"Muhammad","year":"2022","journal-title":"Cancer Res"},{"key":"key20260917101219_b159-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1352101","DOI":"10.3389\/fphar.2024.1352101","article-title":"Plasma free fatty acid levels in cervical cancer: Concurrent chemoradiotherapy improves abnormal profile","volume":"15","author":"Xu","year":"2024","journal-title":"Front Pharmacol"},{"key":"key20260917101219_b160-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.lfs.2018.11.037","article-title":"Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation","volume":"217","author":"Shi","year":"2019","journal-title":"Life Sci"},{"key":"key20260917101219_b161-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"147023","DOI":"10.1016\/j.gene.2022.147023","article-title":"Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt\/mTOR signaling pathway","volume":"851","author":"Lin","year":"2023","journal-title":"Gene"},{"key":"key20260917101219_b162-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/1878-0261.13752","article-title":"Combined spatially resolved metabolomics and spatial transcriptomics reveal the mechanism of RACK1-mediated fatty acid synthesis","volume":"19","author":"Xu","year":"2025","journal-title":"Mol Oncol"},{"key":"key20260917101219_b163-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.3390\/ijms21175976","article-title":"HP1\u03b3 sensitizes cervical cancer cells to cisplatin through the suppression of UBE2L3","volume":"21","author":"Yi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b164-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e2412698","DOI":"10.1002\/advs.202412698","article-title":"DNA-PKcs-Driven YAP1 phosphorylation and nuclear translocation: A key regulator of ferroptosis in hyperglycemia-induced cardiac dysfunction in type 1 diabetes","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"key20260917101219_b165-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.7150\/ijbs.102424","article-title":"Targeting mitochondria by lipid-selenium conjugate drug results in malate\/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression","volume":"20","author":"Chang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"key20260917101219_b166-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12935-024-03537-5","article-title":"The recent advancements of ferroptosis of gynecological cancer","volume":"24","author":"Tang","year":"2024","journal-title":"Cancer Cell Int"},{"key":"key20260917101219_b167-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s41419-022-05257-y","article-title":"Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer","volume":"13","author":"Tang","year":"2022","journal-title":"Cell Death Dis"},{"key":"key20260917101219_b168-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e202314710","DOI":"10.1002\/ange.202314710","article-title":"Strikingly high activity of 15-lipoxygenase towards di-polyunsaturated arachidonoyl\/adrenoyl-phosphatidylethanolamines generates peroxidation signals of ferroptotic cell death","volume":"63","author":"Samovich","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"key20260917101219_b169-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jare.2024.04.009","article-title":"Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer","volume":"69","author":"Luo","year":"2025","journal-title":"J Adv Res"},{"key":"key20260917101219_b170-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"9686","DOI":"10.3390\/ijms26199686","article-title":"Metabolic regulation of ferroptosis in breast cancer","volume":"26","author":"Glibetic","year":"2025","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b171-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"188890","DOI":"10.1016\/j.bbcan.2023.188890","article-title":"GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"key20260917101219_b172-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"115415","DOI":"10.1016\/j.biopha.2023.115415","article-title":"The emerging role of ferroptosis in female reproductive disorders","volume":"166","author":"Liu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"key20260917101219_b173-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1158\/0008-5472.CAN-22-1999","article-title":"ASS1-Mediated reductive carboxylation of cytosolic glutamine confers ferroptosis resistance in cancer cells","volume":"83","author":"Hu","year":"2023","journal-title":"Cancer Res"},{"key":"key20260917101219_b174-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"105646","DOI":"10.1016\/j.ebiom.2025.105646","article-title":"VIPAS39 confers ferroptosis resistance in epithelial ovarian cancer through exporting ACSL4","volume":"114","author":"Jiang","year":"2025","journal-title":"EBioMedicine"},{"key":"key20260917101219_b175-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","article-title":"ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"key20260917101219_b176-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/cas.15999","article-title":"SCD1 inhibition enhances the effector functions of CD8(+) T cells via ACAT1-dependent reduction of esterified cholesterol","volume":"115","author":"Sugi","year":"2024","journal-title":"Cancer Sci"},{"key":"key20260917101219_b177-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12944-023-01868-2","article-title":"Etiological relationship between lipid metabolism and endometrial carcinoma","volume":"22","author":"Li","year":"2023","journal-title":"Lipids Health Dis"},{"key":"key20260917101219_b178-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s40001-024-01897-2","article-title":"M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K\/AKT pathway","volume":"29","author":"Guo","year":"2024","journal-title":"Eur J Med Res"},{"key":"key20260917101219_b179-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fimmu.2020.00089","article-title":"BRD4 inhibition by AZD5153 promotes antitumor immunity via depolarizing M2 macrophages","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"key20260917101219_b180-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8(+) T?cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"key20260917101219_b181-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat Commun"},{"key":"key20260917101219_b182-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"eadj3020","DOI":"10.1126\/science.adj3020","article-title":"Nutrient-driven histone code determines exhausted CD8(+) T cell fates","volume":"387","author":"Ma","year":"2025","journal-title":"Science"},{"key":"key20260917101219_b183-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.ccell.2024.11.005","article-title":"Chemotherapy induces myeloid-driven spatially confined T?cell exhaustion in ovarian cancer","volume":"42","author":"Launonen","year":"2024","journal-title":"Cancer Cell"},{"key":"key20260917101219_b184-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e70253","DOI":"10.1002\/ctm2.70253","article-title":"Ferroptosis of T cell in inflammation and tumour immunity","volume":"15","author":"Xia","year":"2025","journal-title":"Clin Transl Med"},{"key":"key20260917101219_b185-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e002138","DOI":"10.1136\/jitc-2020-002138","article-title":"N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells","volume":"9","author":"Sun","year":"2021","journal-title":"J Immunother Cancer"},{"key":"key20260917101219_b186-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1020255","DOI":"10.3389\/fonc.2022.1020255","article-title":"LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"key20260917101219_b187-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"key20260917101219_b188-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-021-03614-z","article-title":"Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy","volume":"594","author":"Correia","year":"2021","journal-title":"Nature"},{"key":"key20260917101219_b189-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/GCO.0000000000000518","article-title":"Cell-based immunotherapy in gynecologic malignancies","volume":"31","author":"Schaar","year":"2019","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key20260917101219_b190-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"150673","DOI":"10.1016\/j.bbrc.2024.150673","article-title":"Screening of potential targets and small-molecule drugs related to lipid metabolism in ovarian cancer based on bioinformatics","volume":"733","author":"Wang","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"key20260917101219_b191-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e70681","DOI":"10.1002\/cam4.70681","article-title":"Navigating metabolic challenges in ovarian cancer: Insights and innovations in drug repurposing","volume":"14","author":"Mikhael","year":"2025","journal-title":"Cancer Med"},{"key":"key20260917101219_b192-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.2147\/DDDT.S462056","article-title":"Targeting WEE1 kinase in gynecological malignancies","volume":"18","author":"Zhang","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"key20260917101219_b193-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/1568009620666200424144303","article-title":"The therapeutic potential of MEK1\/2 inhibitors in the treatment of gynecological cancers: Rational strategies and recent progress","volume":"20","author":"Ghanaatgar-Kasbi","year":"2020","journal-title":"Curr Cancer Drug Targets"},{"key":"key20260917101219_b194-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cmet.2024.01.012","article-title":"Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5","volume":"36","author":"Lai","year":"2024","journal-title":"Cell Metab"},{"key":"key20260917101219_b195-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-022-02315-3","article-title":"Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2\/ITGB6 signaling axis in ovarian cancer","volume":"41","author":"Lin","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260917101219_b196-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12967-015-0511-3","article-title":"Fatty acid synthase overexpression: Target for therapy and reversal of chemoresistance in ovarian cancer","volume":"13","author":"Bauerschlag","year":"2015","journal-title":"J Transl Med"},{"key":"key20260917101219_b197-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11010-019-03644-2","article-title":"SIRT3 promotes the invasion and metastasis of cervical cancer cells by regulating fatty acid synthase","volume":"464","author":"Xu","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"key20260917101219_b198-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/21691401.2019.1576705","article-title":"Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer","volume":"47","author":"Han","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"key20260917101219_b199-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1038\/s41388-025-03564-0","article-title":"FOXA2 sensitizes endometrial carcinoma to progestin-mediated conservative therapy by triggering PR transcriptional activation","volume":"44","author":"Liu","year":"2025","journal-title":"Oncogene"},{"key":"key20260917101219_b200-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/09513590.2017.1407752","article-title":"Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance","volume":"34","author":"Song","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"key20260917101219_b201-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13048-025-01763-7","article-title":"Oleic acid activates TGF\u03b2-Smad3 signaling to promote ovarian cancer progression","volume":"18","author":"Guo","year":"2025","journal-title":"J Ovarian Res"},{"key":"key20260917101219_b202-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41419-025-07571-7","article-title":"IGF2BP3\/ESM1\/KLF10\/BECN1 positive feedback loop: A novel therapeutic target in ovarian cancer via lipid metabolism reprogramming","volume":"16","author":"Gao","year":"2025","journal-title":"Cell Death Dis"},{"key":"key20260917101219_b203-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"8199","DOI":"10.1007\/s11033-020-05760-5","article-title":"Beyond lipid-lowering: Role of statins in endometrial cancer","volume":"47","author":"Hafizz","year":"2020","journal-title":"Mol Biol Rep"},{"key":"key20260917101219_b204-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.2174\/1381612829666230913113808","article-title":"Statin as repurposed drug in ovarian cancer: A comprehensive review","volume":"29","author":"Ahmad","year":"2023","journal-title":"Curr Pharm Des"},{"key":"key20260917101219_b205-ol-32-4-15800","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2026.01.047","article-title":"Metabolic vulnerabilities in ovarian cancer decoding the nexus between nutrient adaptation and therapy resistance","volume-title":"J Adv Res","author":"Guo","year":"2026"},{"key":"key20260917101219_b206-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ygyno.2009.09.034","article-title":"Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein","volume":"116","author":"Scoles","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20260917101219_b207-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1530\/ERC-17-0449","article-title":"The impact of 27-hydroxycholesterol on endometrial cancer proliferation","volume":"25","author":"Gibson","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"key20260917101219_b208-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.3390\/cancers12113469","article-title":"Lipid regulatory proteins as potential therapeutic targets for ovarian cancer in obese women","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20260917101219_b209-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"108327","DOI":"10.1016\/j.abb.2020.108327","article-title":"Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism","volume":"684","author":"Yao","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"key20260917101219_b210-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3390\/ijms26073322","article-title":"Endometrial cancer is associated with altered metabolism and composition of fatty acids","volume":"26","author":"Razghonova","year":"2025","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b211-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/13543784.2018.1558202","article-title":"Investigational PI3K\/AKT\/mTOR inhibitors in development for endometrial cancer","volume":"28","author":"Barra","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"key":"key20260917101219_b212-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"102021","DOI":"10.1016\/j.ctrv.2020.102021","article-title":"Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer","volume":"86","author":"Huang","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"key20260917101219_b213-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"111176","DOI":"10.1016\/j.cbi.2024.111176","article-title":"Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo","volume":"400","author":"Yang","year":"2024","journal-title":"Chem Biol Interact"},{"key":"key20260917101219_b214-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41419-023-06076-5","article-title":"HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway","volume":"14","author":"Han","year":"2023","journal-title":"Cell Death Dis"},{"key":"key20260917101219_b215-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41420-025-02309-y","article-title":"SPHK1 enhances olaparib resistance in ovarian cancer through the NF\u03baB\/NRF2\/ferroptosis pathway","volume":"11","author":"Teng","year":"2025","journal-title":"Cell Death Discov"},{"key":"key20260917101219_b216-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.7150\/thno.70194","article-title":"SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells","volume":"12","author":"Xuan","year":"2022","journal-title":"Theranostics"},{"key":"key20260917101219_b217-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1002\/ccs3.70033","article-title":"Beyond the tumor: Enhancing pancreatic cancer therapy through glutamine metabolism and innovative drug delivery","volume":"19","author":"Su","year":"2025","journal-title":"J Cell Commun Signal"},{"key":"key20260917101219_b218-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1194\/jlr.S092130","article-title":"Treating cancer with phosphatidylinositol-3-kinase inhibitors: Increasing efficacy and overcoming resistance","volume":"60","author":"Paddock","year":"2019","journal-title":"J Lipid Res"},{"key":"key20260917101219_b219-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"189416","DOI":"10.1016\/j.bbcan.2025.189416","article-title":"Targeting lipid metabolism to enhance cancer immunotherapy","volume":"1880","author":"Zhao","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"key20260917101219_b220-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/mc.23795","article-title":"The anthraquinone derivative KA-4s reduces energy metabolism and enhances the sensitivity of ovarian cancer cells to cisplatin","volume":"63","author":"Zhao","year":"2024","journal-title":"Mol Carcinog"},{"key":"key20260917101219_b221-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/ph15020124","article-title":"Response predictive markers and synergistic agents for drug repositioning of statins in ovarian cancer","volume":"15","author":"Kobayashi","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"key20260917101219_b222-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"452","DOI":"10.62347\/KYIY8286","article-title":"GDF15 promotes the resistance of epithelial ovarian cancer cells to gemcitabine via DHCR24-mediated cholesterol metabolism to elevate ABCB1 and ABCC1 levels in lipid rafts","volume":"15","author":"Guo","year":"2025","journal-title":"Am J Cancer Res"},{"key":"key20260917101219_b223-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41419-025-07886-5","article-title":"YY1-induced USP43 drives ferroptosis suppression by FASN stabilization and subsequent activation of SLC7A11 in ovarian cancer","volume":"16","author":"Zhao","year":"2025","journal-title":"Cell Death Dis"},{"key":"key20260917101219_b224-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"109790","DOI":"10.1016\/j.biopha.2019.109790","article-title":"IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway","volume":"123","author":"Cai","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"key20260917101219_b225-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab"},{"key":"key20260917101219_b226-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1102469","DOI":"10.3389\/fmed.2023.1102469","article-title":"Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases","volume":"10","author":"Griffett","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"key20260917101219_b227-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1158\/0008-5472.CAN-19-3360","article-title":"Pharmacologic activation of LXR alters the expression profile of tumor-associated macrophages and the abundance of regulatory T cells in the tumor microenvironment","volume":"81","author":"Carb\u00f3","year":"2021","journal-title":"Cancer Res"},{"key":"key20260917101219_b228-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"eadh1922","DOI":"10.1126\/scisignal.adh1922","article-title":"Blocking lipid synthesis induces DNA damage in prostate cancer and increases cell death caused by PARP inhibition","volume":"17","author":"Ribeiro","year":"2024","journal-title":"Sci Signal"},{"key":"key20260917101219_b229-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/md23040138","article-title":"Marine sponge-derived gukulenin a sensitizes ovarian cancer cells to PARP inhibition via ferroptosis induction","volume":"23","author":"Kim","year":"2025","journal-title":"Mar Drugs"},{"key":"key20260917101219_b230-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1402851","DOI":"10.3389\/fonc.2024.1402851","article-title":"Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance","volume":"14","author":"Berckmans","year":"2024","journal-title":"Front Oncol"},{"key":"key20260917101219_b231-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/1878-0261.13582","article-title":"Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology","volume":"18","author":"Menendez","year":"2024","journal-title":"Mol Oncol"},{"key":"key20260917101219_b232-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.2174\/1389557520666200811100845","article-title":"Recent advances in the development of fatty acid synthase inhibitors as anticancer agents","volume":"20","author":"Singh","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"key20260917101219_b233-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"104910","DOI":"10.1016\/j.critrevonc.2025.104910","article-title":"Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors","volume":"214","author":"Nuzzo","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20260917101219_b234-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"100797","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"key":"key20260917101219_b235-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13048-021-00886-x","article-title":"Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics","volume":"14","author":"Franz","year":"2021","journal-title":"J Ovarian Res"},{"key":"key20260917101219_b236-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1048484","DOI":"10.3389\/fphar.2022.1048484","article-title":"Advances in ovarian cancer treatment using a combination of statins with other drugs","volume":"13","author":"Xia","year":"2023","journal-title":"Front Pharmacol"},{"key":"key20260917101219_b237-ol-32-4-15800","first-page":"2478","article-title":"Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro","volume":"7","author":"Jones","year":"2017","journal-title":"Am J Cancer Res"},{"key":"key20260917101219_b238-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1182\/bloodadvances.2025016107","article-title":"The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery","volume":"9","author":"Osataphan","year":"2025","journal-title":"Blood Adv"},{"key":"key20260917101219_b239-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.3390\/ijms23042170","article-title":"Fatty acid metabolism in ovarian cancer: Therapeutic implications","volume":"23","author":"Yoon","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20260917101219_b240-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"253","DOI":"10.31083\/j.fbl2810253","article-title":"Molecular subtypes of ovarian cancer based on lipid metabolism and glycolysis reveals potential therapeutic targets","volume":"28","author":"Wang","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key20260917101219_b241-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41416-018-0270-z","article-title":"Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism","volume":"119","author":"Niemi","year":"2018","journal-title":"Br J Cancer"},{"key":"key20260917101219_b242-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1158\/1940-6207.CAPR-22-0374","article-title":"The role of statins in the prevention of ovarian and endometrial cancers","volume":"16","author":"Zeleznik","year":"2023","journal-title":"Cancer Prev Res (Phila)"},{"key":"key20260917101219_b243-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/cells12121605","article-title":"The role of CD36 in cancer progression and its value as a therapeutic target","volume":"12","author":"Feng","year":"2023","journal-title":"Cells"},{"key":"key20260917101219_b244-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e004029","DOI":"10.1136\/jitc-2021-004029","article-title":"CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype","volume":"10","author":"Li","year":"2022","journal-title":"J Immunother Cancer"},{"key":"key20260917101219_b245-ol-32-4-15800","doi-asserted-by":"publisher","first-page":"e005627","DOI":"10.1136\/jitc-2022-005627","article-title":"STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer","volume":"11","author":"Ding","year":"2023","journal-title":"J Immunother Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:13:03Z","timestamp":1789629183000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":245,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15800","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}